BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479:537-59. [PMID: 35195253 DOI: 10.1042/BCJ20220016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, Rajaratnam K, Watson BW, Kell DB. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol 2022;21:148. [PMID: 35933347 DOI: 10.1186/s12933-022-01579-5] [Reference Citation Analysis]
2 Wienkamp A, Erpenbeck L, Rossaint J. Platelets in the NETworks interweaving inflammation and thrombosis. Front Immunol 2022;13:953129. [DOI: 10.3389/fimmu.2022.953129] [Reference Citation Analysis]
3 Davies M. Long covid patients travel abroad for expensive and experimental "blood washing". BMJ 2022;378:o1671. [PMID: 35820689 DOI: 10.1136/bmj.o1671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Biancolella M, Colona VL, Mehrian-Shai R, Watt JL, Luzzatto L, Novelli G, Reichardt JKV. COVID-19 2022 update: transition of the pandemic to the endemic phase. Hum Genomics 2022;16:19. [PMID: 35650595 DOI: 10.1186/s40246-022-00392-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Delaney BC, Rayner C, Freyer A, Taylor S, Järte L, MacDermott N, Nurek M. Author response. Br J Gen Pract 2022;72:259-60. [PMID: 35618450 DOI: 10.3399/bjgp22X719549] [Reference Citation Analysis]
6 Sivan M, Greenhalgh T, Milne R, Delaney B. Are vaccines a potential treatment for long covid? BMJ 2022;377:o988. [PMID: 35584848 DOI: 10.1136/bmj.o988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nyström S, Hammarström P. Amyloidogenesis of SARS-CoV-2 Spike Protein. J Am Chem Soc 2022. [PMID: 35579205 DOI: 10.1021/jacs.2c03925] [Reference Citation Analysis]
8 Ameratunga R, Woon ST, Steele R, Lehnert K, Leung E, Brooks AES. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2. Expert Rev Clin Immunol 2022. [PMID: 35510369 DOI: 10.1080/1744666X.2022.2074403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]